Results 91 to 100 of about 11,011 (206)

The effects of denervation and formoterol administration on facial growth

open access: yesAustralasian Orthodontic Journal, 2014
Objective: To identify and demonstrate possible alterations of skeletal structures which might follow either unilateral surgical denervation of the masseter muscle, unilateral intramuscular injection of formoterol directly into the masseter muscle, or ...
Fitzpatrick Brendan   +3 more
doaj   +1 more source

Nebulized formoterol: a review of clinical efficacy and safety in COPD

open access: yes, 2010
Nicholas J Gross1, James F Donohue21Hines VA Hospital, Stritch Loyola School of Medicine, Hines, IL, USA; 2University of North Carolina School of Medicine, Chapel Hill, NC, USAAbstract: A nebulized formulation of formoterol, Perforomist®, 20 &
Nicholas J Gross, James F Donohue
core  

Change in morning PEF following treatment with budesonide pMDI, budesonide/formoterol DPI or budesonide/formoterol pMDI

open access: yes, 2011
Copyright information:Taken from "Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma"International Journal of Clinical Practice 2007;61(11):1874-1883.Published online Jan 2007PMCID ...
S Peterson (96080)   +3 more
core   +1 more source

Role of inhaled corticosteroids/formoterol in relieving acute asthma as compared to traditional salbutamol in children 6 to 11 years old on maintenance and reliever therapy step 3 and above as per the Global Initiative for Asthma guideline

open access: yesMonaldi Archives for Chest Disease
The recent Global Initiative for Asthma (GINA) guidelines offer two reliever therapy options for patients on step 3 and above: the more popularly used short-acting β-agonists (SABA) and the newly introduced inhaled corticosteroids (ICS)-formoterol ...
Danish Abdul Aziz, Werdah Viquar
doaj   +1 more source

Beclomethasone/formoterol in the management of COPD: A randomised controlled trial

open access: yes, 2010
Objectives: To evaluate the effect of beclomethasone/formoterol versus budesonide/formoterol (non-inferiority) and versus formoterol (superiority) in patients with severe stable chronic obstructive pulmonary disease (COPD).
Sergio F.   +8 more
core   +1 more source

SIMVASTATIN INDUCED HISTOMORPHOLOGICAL CHANGES IN SKELETAL MUSCLE FIBER OF RATS AND PROTECTIVE EFFECT OF FORMOTEROL COADMINISTRATION

open access: yesPakistan Armed Forces Medical Journal, 2019
Objective: To study Simvastatin induced, qualitative histomorphological changes in skeletal muscle fibers of rats and find protective effect of Formoterol co-administration in Simvastatin induced myopathy.
Abdullah Qamar   +2 more
doaj  

EFFECT OF LONG ACTING β2-AGONISTS ON GROSS MORPHOLOGY OF SKELETAL MUSCLES AND CREATINE PHOSPHOKINASE LEVEL IN SIMVASTATIN INDUCED MYOPATHIES IN RATS

open access: yesPakistan Armed Forces Medical Journal, 2019
Objective: To study the gross morphology of skeletal muscles and plasma Creatinine phosphokinase levels of rats and find effect of long acting β2-agonists co-administration in Statin induced myopathies. Study Design: Quasi experimental study. Place
Abdullah Qamar   +3 more
doaj  

Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma

open access: yes, 2018
BACKGROUND: In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a fast-acting β2-agonist may be an alternative to conventional treatment strategies.METHODS: We conducted a 52-week, double-blind trial involving patients 12 years ...
Christina Keen   +19 more
core   +1 more source

Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study

open access: yes, 2012
SummaryBackgroundTreatment with an inhaled corticosteroid (ICS) and long-acting bronchodilator is recommended for severe/very severe chronic obstructive pulmonary disease (COPD) patients with repeated exacerbations.
Sharafkhaneh, Amir   +9 more
core   +1 more source

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: A randomized, controlled, non-inferiority trial of efficacy and safety

open access: yes, 2012
Objectives. The inhaled corticosteroid fluticasone propionate (fluticasone) and the long-acting β2 agonist formoterol fumarate (formoterol) have been combined in a single aerosol inhaler fluticasone/formoterol (flutiform®).
Bálint Beatrix   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy